ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
Early research shows that overall survival is longer with ramucirumab and pembrolizumab compared with an investigator’s choice SOC in advanced NSCLC.
Lung Cancer
Trial to Evaluate Immune Response After Vaccination in Pediatric Patients With Cancer
Patients in the first arm will undergo single booster vaccination, and patients in the second arm will undergo full revaccination.
Less Biomarker Testing, Greater Risk of Death Seen in NSCLC Patients on Medicaid
Medicaid beneficiaries had a higher risk of death than commercially-insured patients, but the risk of death decreased if Medicaid beneficiaries underwent biomarker testing.
Outcomes Seem No Worse With Stereotactic RT for Brain Mets in SCLC
For patients with SCLC with intracranial metastatic disease (IMD), outcomes appear to be no worse with SRS compared with WBRT.
Medicaid Expansion Affected Overall Survival Rates Among Cancer Patients
Medicaid expansion under the ACA was associated with an increase in two-year overall survival among patients newly diagnosed with cancer.
Digital Symptom Monitoring Improves Outcomes in Patients on Oral Anticancer Drugs
The remote monitoring intervention reduced the rate of grade 3 or higher adverse events and the length of hospital stays.
Younger Cancer Patients May Be at High Risk of Death From COVID-19
Younger patients with cancer are “a high-risk population for poor outcomes from COVID-19,” according to researchers.
Immunotherapy Confers Survival Benefit in NSCLC Patients With Brain Metastasis
Immunotherapy prolonged survival compared with platinum chemotherapy.
Trials Supporting Cancer Drug Approvals Lack Information on Gender
Of more than 100 studies used to support drug approvals, none reported information on the gender of participants.
Blood TMB May Predict Response to Atezolizumab in Non-Small Cell Lung Cancer
Having a high blood tumor mutational burden was associated with a significant improvement in response and a trend toward improvement in survival outcomes.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...